Jpmorgan Chase & CO Becton Dickinson & CO Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,420,887 shares of BDX stock, worth $862 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,420,887

Previous 4,108,263 7.61%

Holding current value

$862 Million

Previous $932 Million 8.65%

% of portfolio

0.08%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$222.79 - $249.08 $69.6 Million - $77.9 Million	312,624 Added 7.61%	4,420,887 $1.01 Billion
Q4 2024 Feb 12, 2025	BUY	$220.02 - $243.75 $19.8 Million - $22 Million	90,052 Added 2.24%	4,108,263 $932 Million
Q3 2024 Dec 26, 2024	SELL	$221.47 - $242.41 $98.2 Million - $107 Million	-443,367 Reduced 9.94%	4,018,211 $969 Million
Q3 2024 Nov 08, 2024	SELL	$221.47 - $242.41 $98.2 Million - $107 Million	-443,367 Reduced 9.94%	4,018,211 $969 Million
Q2 2024 Dec 26, 2024	BUY	$225.07 - $246.17 $99.8 Million - $109 Million	443,367 Added 11.03%	4,461,578 $1.04 Billion
Q2 2024 Aug 12, 2024	SELL	$225.07 - $246.17 $23 Million - $25.1 Million	-102,057 Reduced 2.24%	4,461,578 $1.04 Billion
Q1 2024 Dec 26, 2024	BUY	$233.45 - $247.73 $127 Million - $135 Million	545,424 Added 13.57%	4,563,635 $1.13 Billion
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $29.8 Million - $31.6 Million	-127,670 Reduced 2.72%	4,563,635 $1.13 Billion
Q4 2023 Dec 26, 2024	BUY	$232.24 - $267.23 $156 Million - $180 Million	673,094 Added 16.75%	4,691,305 $1.14 Billion
Q4 2023 Feb 12, 2024	BUY	$232.24 - $267.23 $43.4 Million - $49.9 Million	186,695 Added 4.14%	4,691,305 $1.14 Billion
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $204 Million - $226 Million	798,428 Added 21.54%	4,504,610 $1.16 Billion
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $67.1 Million - $74.7 Million	281,438 Added 8.22%	3,706,182 $978 Million
Q1 2023 May 18, 2023	BUY	$229.71 - $259.35 $30.7 Million - $34.7 Million	133,619 Added 4.06%	3,424,744 $848 Million
Q1 2023 May 11, 2023	SELL	$229.71 - $259.35 $15.8 Million - $17.8 Million	-68,673 Reduced 2.04%	3,291,125 $815 Million
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $5.74 Million - $6.76 Million	-26,306 Reduced 0.78%	3,359,798 $854 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $32.6 Million - $169 Million	-639,642 Reduced 15.89%	3,386,104 $755 Million
Q2 2022 Aug 11, 2022	SELL	$234.74 - $275.42 $81.4 Million - $95.6 Million	-346,945 Reduced 7.93%	4,025,746 $992 Million
Q1 2022 May 11, 2022	SELL	$243.64 - $270.48 $165 Million - $183 Million	-675,916 Reduced 13.39%	4,372,691 $1.13 Billion
Q4 2021 Feb 10, 2022	BUY	$230.08 - $250.94 $93.5 Million - $102 Million	406,458 Added 8.76%	5,048,607 $1.27 Billion
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $1.08 Billion - $1.19 Billion	4,642,149 New	4,642,149 $1.14 Billion

Others Institutions Holding BDX

# of Institutions

1,730

Shares Held

264M

Call Options Held

2.08M

Put Options Held

728K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $55.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Becton Dickinson & CO Transaction History